Results 281 to 290 of about 189,433 (365)
Molecular mechanisms and therapeutic strategies for neuromuscular diseases. [PDF]
Zambon AA+3 more
europepmc +1 more source
An Expanded Access Protocol of RNS60 in Amyotrophic Lateral Sclerosis
ABSTRACT Aims RNS60 is an investigational product in clinical development for amyotrophic lateral sclerosis (ALS). RNS60 slowed disease progression in the ALS SOD1G93A mouse model and was safe and well tolerated both in an open‐label pilot study and a randomized, placebo‐controlled, multicenter phase 2 trial in people living with ALS.
Grace Addy+22 more
wiley +1 more source
Patient-reported daily functioning after SARS-CoV-2 vaccinations in autoimmune neuromuscular diseases. [PDF]
van Dam KPJ+19 more
europepmc +1 more source
ABSTRACT Introduction/Aims Accurate measurement of knee‐extensor strength in people with inclusion body myositis (IBM) is vital to track disease progression and provide a standardized outcome for clinical trials. Isokinetic dynamometers are the current gold standard tool for measuring knee‐extensor strength. A less costly, more portable tool would have
Katie Schütze+7 more
wiley +1 more source
Prevalence of Elevated CK Levels, Myositis-Specific and Myositis-Associated Antibodies, Myositis, and Other Neuromuscular Diseases in Myasthenia Gravis Patients-Experience from an Eastern European Tertiary Center. [PDF]
Kozák M+4 more
europepmc +1 more source
ABSTRACT Introduction/Aims Speech intelligibility decline is a common in dysarthria secondary to amyotrophic lateral sclerosis (ALS). However, interventions that focus on improving speech may not be able to counteract decline as the disease progresses.
Annie J. Olmstead+3 more
wiley +1 more source
Indications and techniques of non-invasive ventilation (NIV) in neuromuscular diseases. [PDF]
Annunziata A+6 more
europepmc +1 more source
ABSTRACT Introduction/Aims Hereditary transthyretin amyloidosis (ATTRv) is an autosomal dominant multisystem disorder that occurs worldwide. The most common mutation in the United States, V142I, has previously been described as having a primarily cardiac presentation.
Urvi Desai+3 more
wiley +1 more source